参考文献

1.Gross S，Cairns RA，Minden MD，et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med，2010，207：339-344.

2.Gravendeel LA，Kloosterhof NK，Bralten LB，et al. Segregation of non-p. R132H mutations in IDH1 in distinct molecular subtypes of glioma. Hum Mutat，2010，31：E1186-E1199.

3.van den Bent MJ，Dubbink HJ，Marie Y，et al. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors：a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res，2010，16：1597-1604.

4.Reimenschneider M，Jeuken JW，Wesseling P，et al. Molecular diagnostics of gliomas：state of the art. Acta Neuropathol，2010，120：567-584.

5.Schlosser S，Wagner S，Muhlisch J，et al. MGMT as a potential stratifi cation marker in relapsed high-grade glioma of children：the HIT-GBM experience. Pediatr Blood Cancer，2010，54：228-237.

6.Nikiforova M，Hamilton R. Molecular diagnostics of gliomas. Arch Pathol Lab Med，2011，135：558-568.

7.Rivera AL，Pelloski CE，Gilbert MR，et al. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro Oncol，2010，12：116-121.

8.Weller M，Stupp R，Reifenberger G，et al. MGMT promotor methylation in malignant gliomas：ready for personalized medicine？Nat Rev Neurol，2010，6：39-51.

9.Levidou G，El-Habr E，Saetta AA，et al. P53 immunoexpression as a prognostic marker for human astrocytomas：a meta-analysis and review of the literature. J Neurooncol，2010，100：363-371.

10.Deighton RF，McGregor R，Kemp J，et al. Glioma pathophysiology：insights emerging from proteomics. Brain Pathol，2010，20：691-703.

11.Labussiere M，Idbaih A，Wang XW，et al. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology，2010，74：1886-1890.

12.Paugh BS，Qu C，Jones C，et al. Integrated molecular genetic profi ling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol，2010，28：3061-3068.